We have generated Thy-1
Specific changes in the composition of the cell surface are thought to play a crucial role in development. It is therefore important to understand how the expression of surface molecules is regulated. A good example is Thy-1, a small glycoprotein that appears on a number of cell types at particular stages of development (see ref. 1 for review). It is the simplest well-characterized member of the immunoglobulin superfamily of molecules (2) (3) (4) . No biological role has yet been demonstrated for Thy-1, although it is capable of modulating intracellular Ca2l levels (5) . It appears at high levels on nervous tissue and is a substantial component ofthe neuronal surface (1) . In other tissues, it shows marked differences between species; e.g., in mice Thy-1 is a marker for mature T lymphocytes (6) , whereas in humans it is not found on these cells (7) .
The Thy-1 gene from mouse (8, 9) and humans (10, 11) has been cloned and completely characterized. The mouse gene contains two promoters with two alternative exons, which are spliced onto the same second exon (Fig. 1) . Both promoters are G+C-rich, lack the "TATA box" (8, 12) , and are part of a methylation-free "island" (unpublished data). Such islands are characteristic of "housekeeping" genes but have also been found in some tissue-specific genes (13) .
The pattern of expression of the Thy-1 gene suggests that different regulatory elements may be involved in its tissueand development-specific regulation. In this paper we describe Thy-i expression in transgenic mice and show that the gene is under the control of different regulatory elements in brain and lymphoid tissue.
MATERIALS AND METHODS
Microinjection and Nucleic Acid Analysis. F2 fertilized eggs of CBA x C57BL/10 parents were injected with -"2 pl of 10 mM Tris Cl, pH 7.5/0.1 mM EDTA containing DNA at -2 ,g/ml. The microinjected eggs were transferred into pseudopregnant females (14, 15) . Ten days after birth, the pups were analyzed by Southern blot analysis of tail DNA (16) .
RNA isolation and nuclease Si-protection analysis were carried out as described (15) . Transcription assays in nuclei from transgenic (Tgl2) brain, thymus, spleen, and liver and normal (CBA x C57BL/10)F1 thymus were performed according to Linial et al. (17) .
Immunological Assays. Thy-1.1 was detected by means of monoclonal antibody OX7 (18) , and Thy-1.2, by means of monoclonal antibody 30-H12 (19) . Radioimmunoassays were done (20) with tissue homogenates (brain, kidney, liver) or suspensions of viable cells (thymocytes), with the same tissues from age-matched A/Thy-1.1 mice (for Thy-1.1) or nontransgenic CBA x C57BL littermates (for Thy-1.2) as controls. In some experiments, thymocytes were divided into two aliquots, to one of which 15% Triton X-100 was added to 1% (wt/vol), and the lysed cells were diluted in 0.1% Triton X-100 in phosphate-buffered saline for assay (21) . For immunohistochemistry, acetic acid/alcohol-fixed sections of brain (22) and acetone-fixed cryostat sections of lymphoid tissue were used, with horseradish peroxidase (HRP)-conjugated OX7 F(ab')2 to visualize Thy-1.1 or 30-H12 followed by HRP-conjugated rat immunoglobulin-specific antibodies as a second layer for Thy-1.2. Endogenous peroxidase was blocked by a 30-min preincubation in 0.5% H202 in methanol. T-lymphocyte subsets were identified by using rat monoclonal antibodies YTS 191 (to L3T4) and YTS 169.4 (to Lyt-2) (23). B lymphocytes were identified using HRP-conjugated rabbit anti-mouse IgG (22) . Immunofluorescence-labeled lymphoid cells were counted under a fluorescence microscope, fixed in 1% formalin in phosphate-buffered saline at 4°C, and analyzed on an EPICS-C fluorocytometer (Coulter). For purification of T lymphocytes, a spleen-cell suspension in RPMI 1640 medium was centrifuged over Histopaque-1077 (Sigma), cultured on plastic for 2 hr to remove adherent cells, and then passed down a nylon wool column.
RESULTS
Production and Characterization of Transgenic Mice. The Thy-i gene (Fig. 1) This developmental rise of both exogenous and endogenous Thy-1 was reflected in the steady-state mRNA levels ( Fig. 3 ) detected in whole brain from 8-day-or 8-week-old animals (at day 0, the mRNA was barely detectable; data not shown). The amount of transferred-gene RNA increased to a level that was 9-fold higher than the level of the endogenous RNA after correction for the 3-fold difference in probe specific activity. In comparison, the level of mouse histone H4 RNA did not increase (Fig. 3 Inset) .
To examine the cell-type expression, adjacent serial sections of brains of mice ranging from 11 to 84 days old were stained for Thy- Tgi2. RNA (30 ,ug) was hybridized at 520C to a 680-nucleotide (nt) BamHI 3'-end-labeled probe from the 3' end of the Thy-1.2 gene and a 950-nt Nco I-Bgl II 3'-end-labeled probe from the 3' end of the human Thy-1 gene (see diagram below autoradiographs). Normally, the endogenous Thy-1.2 gene produces an mRNA that protects a probe fragment of 115 nt from nuclease S1 digestion. Normal transcription from the mouse-human hybrid gene produces a major mRNA that protects a probe fragment of 165 nt from S1 digestion. A minor band at 400 nt represents a second poly(A)-addition site for the transgenic mRNA. The ratio of specific activity of the mouse Thy-1. staining with each antibody was identical, although the anti-Thy-i.i labeling was considerably more intense. In adult brain, Thy-i.i immunohistochemistry showed the transgenic molecule to be predominantly on neuronal plasma membranes, although some cytoplasmic staining [of newly synthesized antigen (1) ] occurred above the nucleus in large neurons (Fig. 4a) . Transgenic antigen was not found in the Thy-l-negative axons of the olfactory nerve (Fig. 4b) (Fig. 4c) . Later in development, the Purkinje cells lacked detectable Thy-1.1; instead, it appeared on the granule cell axons lying between the Purkinje dendrites (Fig. 4d) .
Despite a transferred-gene copy number of 20 (Fig. 2) . Within the thymus, both antigens showed the appropriate distribution by immunohistochemical analysis (Fig. 5) Biochemistry: Kofflas et al.
these two tissues (Fig. 3) . Comparable levels of Thy-1.1 and Thy-1.2 RNA were found after correction for probe specific activity. Moreover, the total level of RNA was lower than in the brain when compared to the histone H4 RNA control (Inset) .
Peripheral T-lymphocytes. Although expression of the exogenous gene on adult thymocytes was reduced compared to brain, on peripheral T lymphocytes expression of transgenic Thy-1.1 was extinguished entirely. Immunofluorescence analysis of spleen cell suspensions showed that in adult Tg12, Tgli, and Tg9 mice, 30-35% of the nucleated spleen cells were Thy-1.2-positive, as in normal littermates. However, essentially no cells (0-4%) were Thy-1.2-positive. As expected, 40-45% of cells (the B lymphocytes) reacted with secondary anti-immunoglobulin antibodies alone. This was confirmed by immunohistochemistry on sections of spleen and lymph node. Anti-Thy-1.2 antibodies (Fig. 5 c and e) and anti-immunoglobulin antibodies labeled cells in the T and B areas, respectively. Immunolabeling with antibodies to T-lymphocyte subsets (anti-L3T4, anti-Lyt-2) confirmed the normality of the T-lymphocyte composition in the transgenic mice (data not shown). However, anti-Thy-1.1 antibody failed to stain any cells in these sections (Fig. 5 d and  f) . This was also true (data not shown) for two Tgi2 mice at 11 days of age, when the thymocyte Thy-1.1 level is still elevated (Fig. 2) .
The mRNA levels reflected this absence of Thy-1.1 from spleen cells: mRNA from the endogenous Thy-1.2 gene, but not the Thy-1.1 gene, could be detected (Fig. 3) . To assess whether this difference occurred at the level of transcription or RNA stabilization, transcription assays were done on nuclei isolated from several tissues (Fig. 6) , and the newly synthesized RNA was hybridized to 3'-end probes specific were the same as observed for the protein or steady-state RNA levels; 8-to 10-fold more radioactive RNA hybridized to the human 3'-end-specific probe than to the mouse 3'-end-specific probe. In contrast, splenic T lymphocytes showed transcription of the endogenous gene but not of the transferred gene. The total level of endogenous Thy-1.2 transcription in the spleen was considerably lower (by a factor of 10) than in the thymus, reflecting the lower percentage of T lymphocytes in spleen (-30%) and the normal decrease (25%) in surface Thy-1 on peripheral T lymphocytes. Liver, which is at this stage still a hematopoietic tissue, showed a mixed pattern: it contains both early progenitors and late T lymphocytes resulting in a slightly higher level of endogenous expression (early and late cells), compared to the transferred-gene expression (early cells only). By 8 weeks, there was no detectable Thy-1.1 in the liver (data not shown). Intron probes excluded RNA processing as a factor in the observed differences (data not shown).
Finally, the possibility that the Thy-1.1 gene was deleted in peripheral T lymphocytes was investigated. Southern 
DISCUSSION
The very high expression of the transgenic Thy-i.i in these brains was the result of enhanced levels of transcription, as evidenced by the mRNA levels and transcriptional run-off experiments. This was probably caused by the high copy number of the injected gene, although there was no strict correlation between copy number and the level ofexpression. The remarkable feature of the quantitatively enhanced expression of the exogenous gene in brain is the fidelity of developmental, and cell-specific, regulation. This argues strongly that the fragment (Fig. 1 ) that was used for the injection contains all the regulatory elements necessary for appropriate nervous tissue expression.
In contrast, not all the regulatory elements required in murine lymphocytes are present. In mouse, Thy-1 is found at low levels on some progenitors of thymocytes (21, 27) (1987) indirect support to this second possibility (E.S., unpublished data). Consequently, Thy-1 expression in murine T-lineage cells might be regulated by at least two cis-acting DNA sequences, one (or more) contained within the EcoRI fragment and one upstream of this fragment. Expression in the murine thymus might use both these elements to obtain maximal levels of expression. When the cells mature and move to the periphery, only one of the elements (missing from the mouse-human construct) would be used, resulting in the normal drop in the levels of transcription of the endogenous gene. Transcription of the transferred gene would cease altogether because it lacks this element.
The elevated levels of Thy-1.1 on thymocytes in young mice were measured on the cell surface (using viable cells), and the immunohistochemical evidence strongly suggests that in brain also, the 7-to 16- 
